|
1
|
Centers for Disease Control and Prevention
(CDC): Prevalence of doctor - diagnosed arthritis and arthritis -
attributable activity limitation - United States, 2007–2009. MMWR
Morb Mortal Wkly Rep. 59:1261–1265. 2010.
|
|
2
|
Buckwalter JA and Mankin HJ: Articular
cartilage repair and transplantation. Arthritis Rheum.
41:1331–1342. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van den Berg WB, van der Kraan PM,
Scharstuhl A and van Beuningen HM: Growth factors and cartilage
repair. Clin Orthop Relat Res. 391(Suppl): S244–S250. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fiorentino DF, Bond MW and Mosmann TR: Two
types of mouse T helper cell. IV. Th2 clones secrete a factor that
inhibits cytokine production by Th1 clones. J Exp Med.
170:2081–2095. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moore KW, de Waal Malefyt R, Coffman RL
and O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu
Rev Immunol. 19:683–765. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moroguchi A, Ishimura K, Okano K,
Wakabayashi H, Maeba T and Maeta H: Interleukin-10 suppresses
proliferation and remodeling of extracellular matrix of cultured
human skin fibroblasts. Eur Surg Res. 36:39–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reitamo S, Remitz A, Tamai K and Uitto J:
Interleukin-10 modulates type I collagen and matrix metalloprotease
gene expression in cultured human skin fibroblasts. J Clin Invest.
94:2489–2492. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamamoto T, Eckes B and Krieg T: Effect of
interleukin-10 on the gene expression of type I collagen,
fibronectin, and decorin in human skin fibroblasts: Differential
regulation by transforming growth factor-beta and monocyte
chemoattractant protein-1. Biochem Biophys Res Commun. 281:200–205.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Virk MS, Conduah A, Park SH, Liu N,
Sugiyama O, Cuomo A, Kang C and Lieberman JR: Influence of
short-term adenoviral vector and prolonged lentiviral vector
mediated bone morphogenetic protein-2 expression on the quality of
bone repair in a rat femoral defect model. Bone. 42:921–931. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Naldini L, Blömer U, Gage FH, Trono D and
Verma IM: Efficient transfer, integration, and sustained long-term
expression of the transgene in adult rat brains injected with a
lentiviral vector. Proc Natl Acad Sci USA. 93:11382–11388. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naldini L, Blömer U, Gallay P, Ory D,
Mulligan R, Gage FH, Verma IM and Trono D: In vivo gene delivery
and stable transduction of nondividing cells by a lentiviral
vector. Science. 272:263–267. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Manilla P, Rebello T, Afable C, Lu X,
Slepushkin V, Humeau LM, Schonely K, Ni Y, Binder GK, Levine BL, et
al: Regulatory considerations for novel gene therapy products: A
review of the process leading to the first clinical lentiviral
vector. Hum Gene Ther. 16:17–25. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sugiyama O, An DS, Kung SP, Feeley BT,
Gamradt S, Liu NQ, Chen IS and Lieberman JR: Lentivirus-mediated
gene transfer induces long-term transgene expression of BMP-2 in
vitro and new bone formation in vivo. Mol Ther. 11:390–398. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baltzer AW and Lieberman JR: Regional gene
therapy to enhance bone repair. Gene Ther. 11:344–350. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lieberman JR: Orthopaedic gene therapy.
Fracture healing and other nongenetic problems of bone. Clin Orthop
Relat Res. (Suppl): S156–S158. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lieberman JR, Ghivizzani SC and Evans CH:
Gene transfer approaches to the healing of bone and cartilage. Mol
Ther. 6:141–147. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gamradt SC and Lieberman JR: Genetic
modification of stem cells to enhance bone repair. Ann Biomed Eng.
32:136–147. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hannallah D, Peterson B, Lieberman JR, Fu
FH and Huard J: Gene therapy in orthopaedic surgery. Instr Course
Lect. 52:753–768. 2003.PubMed/NCBI
|
|
20
|
Jones AL, Bucholz RW, Bosse MJ, Mirza SK,
Lyon TR, Webb LX, Pollak AN, Golden JD and Valentin-Opran A; BMP-2
Evaluation in Surgery for Tibial Trauma-Allgraft (BESTT-ALL) Study
Group: Recombinant human BMP-2 and allograft compared with
autogenous bone graft for reconstruction of diaphyseal tibial
fractures with cortical defects. A randomized, controlled trial. J
Bone Joint Surg Am. 88:1431–1441. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vaccaro AR, Whang PG, Patel T, Phillips
FM, Anderson DG, Albert TJ, Hilibrand AS, Brower RS, Kurd MF,
Appannagari A, et al: The safety and efficacy of OP-1 (rhBMP-7) as
a replacement for iliac crest autograft for posterolateral lumbar
arthrodesis: Minimum 4-year follow-up of a pilot study. Spine J.
8:457–465. 2008. View Article : Google Scholar
|
|
22
|
Swiontkowski MF, Aro HT, Donell S,
Esterhai JL, Goulet J, Jones A, Kregor PJ, Nordsletten L, Paiement
G and Patel A: Recombinant human bone morphogenetic protein-2 in
open tibial fractures. A subgroup analysis of data combined from
two prospective randomized studies. J Bone Joint Surg Am.
88:1258–1265. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Blanco Garcia FJ: Catabolic events in
osteoarthritic cartilage. Osteoarthritis Cartilage. 7:308–309.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fernandes JC, Martel-Pelletier J and
Pelletier JP: The role of cytokines in osteoarthritis
pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
|
|
25
|
Goldring SR and Goldring MB: The role of
cytokines in cartilage matrix degeneration in osteoarthritis. Clin
Orthop Relat Res. 427(Suppl): S27–S36. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
D'Lima D, Hermida J, Hashimoto S, Colwell
C and Lotz M: Caspase inhibitors reduce severity of cartilage
lesions in experimental osteoarthritis. Arthritis Rheum.
54:1814–1821. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blanco FJ, López-Armada MJ and Maneiro E:
Mitochondrial dysfunction in osteoarthritis. Mitochondrion.
4:715–728. 2004. View Article : Google Scholar
|
|
28
|
Iannone F, De Bari C, Dell'Accio F,
Covelli M, Cantatore FP, Patella V, Lo Bianco G and Lapadula G:
Interleukin-10 and interleukin-10 receptor in human osteoarthritic
and healthy chondrocytes. Clin Exp Rheumatol. 19:139–145.
2001.PubMed/NCBI
|
|
29
|
Dayer JM: Cytokines and anti-cytokines in
inflammatory rheumatism. Rev Rhum Ed Fr. 61:173S–180S. 1994.In
French.
|
|
30
|
Isomäki P and Punnonen J: Pro- and
anti-inflammatory cytokines in rheumatoid arthritis. Ann Med.
29:499–507. 1997. View Article : Google Scholar
|
|
31
|
Jorgensen C, Apparailly F, Couret I,
Canovas F, Jacquet C and Sany J: Interleukin-4 and interleukin-10
are chondroprotective and decrease mononuclear cell recruitment in
human rheumatoid synovium in vivo. Immunology. 93:518–523. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gonzalez-Rey E, Chorny A, Del Moral RG,
Varela N and Delgado M: Therapeutic effect of cortistatin on
experimental arthritis by downregulating inflammatory and Th1
responses. Ann Rheum Dis. 66:582–588. 2007. View Article : Google Scholar
|
|
33
|
Zhou JH, Broussard SR, Strle K, Freund GG,
Johnson RW, Dantzer R and Kelley KW: IL-10 inhibits apoptosis of
promyeloid cells by activating insulin receptor substrate-2 and
phosphatidylinositol 3′-kinase. J Immunol. 167:4436–4442. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bouton LA, Ramirez CD, Bailey DP, Yeatman
CF, Yue J, Wright HV, Domen J, Rosato RR, Grant S, Fischer-Stenger
K, et al: Costimulation with interleukin-4 and interleukin-10
induces mast cell apoptosis and cell-cycle arrest: The role of p53
and the mitochondrion. Exp Hematol. 32:1137–1145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rojas M, Olivier M, Gros P, Barrera LF and
García LF: TNF-alpha and IL-10 modulate the induction of apoptosis
by virulent Mycobacterium tuberculosis in murine macrophages. J
Immunol. 162:6122–6131. 1999.PubMed/NCBI
|
|
36
|
Bharhani MS, Borojevic R, Basak S, Ho E,
Zhou P and Croitoru K: IL-10 protects mouse intestinal epithelial
cells from Fas-induced apoptosis via modulating Fas expression and
altering caspase-8 and FLIP expression. Am J Physiol Gastrointest
Liver Physiol. 291:G820–G829. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y and Lou S: Direct protective effect
of interleukin-10 on articular chondrocytes in vitro. Chin Med J
(Engl). 114:723–725. 2001.
|
|
38
|
Fischer BA, Mundle S and Cole AA: Tumor
necrosis factor-alpha induced DNA cleavage in human articular
chondrocytes may involve multiple endonucleolytic activities during
apoptosis. Microsc Res Tech. 50:236–242. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aizawa T, Kon T, Einhorn TA and
Gerstenfeld LC: Induction of apoptosis in chondrocytes by tumor
necrosis factor-alpha. J Orthop Res. 19:785–796. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aigner T and Kim HA: Apoptosis and
cellular vitality: Issues in osteoarthritic cartilage degeneration.
Arthritis Rheum. 46:1986–1996. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schuerwegh AJ, Dombrecht EJ, Stevens WJ,
Van Offel JF, Bridts CH and De Clerck LS: Influence of
pro-inflammatory (IL-1 alpha, IL-6, TNF-alpha, IFN-gamma) and
anti-inflammatory (IL-4) cytokines on chondrocyte function.
Osteoarthritis Cartilage. 11:681–687. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Heyninck K and Beyaert R: Crosstalk
between NF-kappaB-activating and apoptosis-inducing proteins of the
TNF-receptor complex. Mol Cell Biol Res Commun. 4:259–265. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kühn K, Hashimoto S and Lotz M: IL-1 beta
protects human chondrocytes from CD95-induced apoptosis. J Immunol.
164:2233–2239. 2000. View Article : Google Scholar : PubMed/NCBI
|
